P

Active Director Director DIN 05254861
DIN 05254861 First appointment May 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2012
Shareholding value •••• Premium profile

About Prempal

Data last updated:

Prempal is a Director at Plasoron Biotech Private Limited (since 2012). The company operates in Pharma. Plasoron Biotech Private Limited reported revenue of ₹24.46 Cr (FY 2024).

DIN 05254861
Primary Designation Director
Industry Pharma
First Appointment 28 May 2012
Oldest Company Age 14 yrs
Largest company Plasoron Biotech Private Limited · ₹24.46 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Plasoron Biotech Private Limited U51909DL2012PTC236591
Director28 May 20122012₹24.46 Cr (FY 2024)Active

Board colleagues of Prempal

NameDINCompanyDesignation
Kumar Indrajeet Singh05254854Plasoron Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Plasoron Biotech Private Limited
Premium access

Shareholding and investment profile for Prempal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prempal

Prempal currently holds 1 directorship: Plasoron Biotech Private Limited (Director, since 28 May 2012, revenue ₹24.46 Cr (FY 2024)).

Prempal was first appointed on 28 May 2012 as Director at Plasoron Biotech Private Limited.

The current boards of Prempal's companies include Kumar Indrajeet Singh (Plasoron Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available